AlphAIAlphAI — Financial news for AI agents
investing.comAUG 252 min read$SLQT

Why is Selectquote stock sliding today?

Selectquote (SLQT) shares dropped 16.59% in pre-market trading to $0.643 after missing Q4 2026 earnings and revenue estimates. The company reported a loss of $0.19 per share and $321.7M in revenue, while FY2027 guidance of $1.35B-$1.45B fell below consensus. Analysts had already lowered ratings due to sector headwinds, including Medicare Advantage marketing cuts and reimbursement pressures.

Original reporting
investing.com
Published Aug 25, 2026, 11:54 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 12:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$SLQT
Bearish
high confidence
Mentioned
$SLQT
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$SLQTBearishHigh
01

Why it matters

The earnings miss and weak guidance are likely to trigger short‑term price declines, with volatility spikes in the trading day.

02

Market read

Earnings surprise and guidance shortfall create immediate trading opportunity for SLQT; sector peers may be affected.

03

What to watch

Potential cost‑cutting measures and upcoming product initiatives not disclosed in the release.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

SelectQuote reported Q4 2026 results and FY2027 guidance, missing analyst expectations and prompting a sharp pre‑market sell‑off.

Company-level read

Ticker impact

$SLQTBearishHigh confidence
Context

Q4 2026 earnings miss and FY2027 revenue guidance below consensus triggered a 16.6% pre‑market drop.

Expected impact

Further downside pressure if guidance remains unchanged; potential bounce if management clarifies growth path.

Evidence & confidence

The combination of a loss per share worse than estimates, revenue shortfall, and guidance $200M below consensus drives immediate sell pressure.

Market effects

Sector

Medicare insurance distribution sector faces headwinds from payer reimbursement pressure.

Regional

U.S. health‑insurance brokerage stocks may see broader weakness.

Global

Limited to U.S. market; no direct global effect.

Counterpoint

What could challenge this read

If the company can secure new payer contracts, the stock may be oversold after the sharp drop.

Key entities

  • company
    SelectQuote, Inc.

    U.S. listed health‑insurance brokerage (ticker SLQT).

Read at source← All news

Also covered by

1 outlet

Related articles

SEP 1
$SLQTHighAI 8/10

SelectQuote (SLQT) Q4 2026 Earnings Call Transcript

SelectQuote reported fiscal 2026 revenue of $1.6B, up 6% YoY, with adjusted EBITDA of $109.1M. Healthcare Services revenue grew 14% to $845M. Fiscal 2027 guidance includes revenue of $1.35B-$1.45B and adjusted EBITDA of $90M-$115M. Management highlighted cash flow improvement and debt reduction strategies, noting industry volatility in Medicare Advantage.

aol.com3 min
SEP 1
$SLQTMedAI 8/10

SelectQuote’s (SLQT) Cash Flow Pitch Comes With A Shrinking Top Line

SelectQuote (SLQT) reported fiscal 2026 revenue of $1.62B, up 6% YoY, with operating cash flow increasing $44M. However, it posted a Q4 net loss of $16.8M and guided fiscal 2027 revenue lower. Healthcare Services revenue grew 14% to $845M, despite drug pricing changes. The company identified $30M in annual savings from AI tools. Guidance expects fiscal 2027 revenue to decline 14% at the midpoint, with Medicare Advantage policies projected to fall further.

yahoo.com2 min
AUG 25
$SLQTMedAI 8/10

SelectQuote Q4 Earnings Call Highlights

SelectQuote (SLQT) reported Q4 Healthcare Services membership at 109,000, with expected revenue decline of 10-15% in fiscal 2027 due to the Inflation Reduction Act. Senior segment revenue fell 4% to $576M but maintained 26% EBITDA margins. Life insurance revenue rose 8% to $186M. The company guided fiscal 2027 revenue at $1.35B-$1.45B and adjusted EBITDA at $90M-$115M, with cash flow doubling.

yahoo.com2 min
AUG 25
$SLQTHighAI 8/10

SelectQuote Shares Slide After Q4 Revenue Miss and Weak Fiscal 2027 Outlook

SelectQuote (SLQT) shares fell 14.69% in pre-market trading after reporting Q4 fiscal 2026 revenue of $321.7M, missing estimates, and issuing a fiscal 2027 revenue outlook of $1.35B-$1.45B, below consensus. The company reported a net loss of $16.8M, though adjusted EBITDA improved. CEO Tim Danker highlighted success in the Senior Medicare Advantage segment.

yahoo.com3 min
AUG 25
$SLQTHigh

SelectQuote, Inc. (SLQT): Results of Operations and Financial Condition

SelectQuote, Inc. (SLQT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SelectQuote, Inc. Reports Fourth Quarter of Fiscal Year 2026 Results Fourth Quarter of Fiscal Year 2026 – Consolidated Earnings Highlights • Revenue of $321.7 million • Net loss of $(16.8) million • Adjusted EBITDA* of $11.9 million Fiscal Year 2027 Guidance Ranges:

SEC EDGAR 8-K2 min
SEP 17
$CRWDMedAI 8/10

Jim Cramer Highlights CrowdStrike (CRWD) as AI Security Concerns Lift Cybersecurity Stocks

CrowdStrike (CRWD) rose 14% after Jim Cramer highlighted its AI-driven cybersecurity opportunities. Q2 revenue grew 26% to $1.47B, with ARR up 25% to $5.84B. The company raised its full-year net new ARR growth outlook to 34%. CEO George Kurtz emphasized AI threats and CrowdStrike's solutions. The stock's high valuation (forward P/E 188.7x) leaves little room for growth slowdowns.

insidermonkey.com2 min